e-ISSN: 2394-2967
logo

British Journal of Medical and Health Research

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

Volume 10, Issue 7 - 2023 (July 2023 Issue 7)

Volume 10 Issue 7 Cover

Issue Details:

Volume 10 Issue 7
Published:Invalid Date

Editorial: July 2023 Issue 7

Welcome to the 2023 issue of British Journal of Medical and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr Hemangi J Patel
Editor-in-Chief
British Journal of Medical and Health Research

Articles in This Issue

Showing 2 of 2 articles
Research PaperID: BJMHR1007001

Implementation of Quality Control Tests for two Digital X-Ray Equipment in Riyadh

Mohammed A. Alnafea, Jawhara A. Annab

ABSTRACT The main aim of diagnostic radiology is to deliver high-quality diagnostic image information regarding anatomic detail or an ongoing physiological process within a patient's body, when such information cannot be provided by an alternate diagnostic method that does not require ionizing radiation. The major purpose of the quality assurance (QA) program of radiological practice optimization is to ensure enough clinical diagnostic information while exposing the patient to the least amount of radiation possible (as low as reasonably achievable ALARA principle) at the lowest cost. Implementing the QA program entails more than just completing legal requirements for quality control (QC) of X-ray and associated equipment and the regions where they are installed; it also entails making the best use of equipment, human, and material resources, as well as patient dosage monitoring during articular radiographic diagnostic procedures. The main objective of this study was to perform QC tests on stationary radiographic X-ray machines, installed in two hospitals of Riyadh city, Saudi Arabia. Based on the findings, kVp accuracy, kVp reproducibility, timer accuracy, timer reproducibility, exposure reproducibility, mA/timer linearity, and half-value layer were within the acceptable limits. Thus the result of the two X-Ray machines passed all the QC tests. Keywords: Diagnostic X-ray, Quality Assurance, Quality Control, X-ray meter, Radiology Device

Diagnostic X-rayQuality AssuranceQuality ControlX-ray meterRadiology Device
56,558 views
17,001 downloads

Contributors:

 Mohammed A. Alnafea
,
 Jawhara A. Annab
Research PaperID: BJMHR1007002

Synergistic Assessment of the Antimicrobial Activities of Sida acuta, Dioscorea bulbifera and Citrus aurantifolia Extracts on Selected Bacteria

Amadi-Wali Owhorchukwu, Azuonwu Obioma, Amala Smart Enoch, Wokem Gloria Ngozika

ABSTRACT Synergy refers to the combination and interaction of two or more agents which produces a result that is greater than the sum of their individual effects. Hence, the synergistic assessment of the effects of Sida acuta & Citrus aurantifolia, Sida acuta & Dioscorea bulbifera and Citrus aurantifolia & Dioscorea bulbifera combined extracts on selected bacteria (Escherichia coli0157:H7, Salmonella typhymurium and Vibrio cholerae) were investigated. The study area was Omuanwa in Ikwerre Local Government Area of Rivers State, Nigeria were the plants were collected. The test organisms were identified by polymerase chain reaction technique, while the antimicrobial effects of the combined plant extracts were examined against the different bacterial species by agar well diffusion method and sensitivity interpreted in accordance with the Clinical and Laboratory Standard Institute. Phytochemicals extracted were Flavonoids, Cardiac Glycosides, Tannin, Phenols, Alkaloids, Steroids, Terpenoid and Saponins, however, the concentrations of phytochemicals extracted by ethanol and aqueous showed statistical significant difference of p<0.05. The organisms were more sensitive to Citrus aurantifolia & Sida acuta with 91.7%, followed by Citrus aurantifolia & Dioscorea bulbifera and Sida acuta & Dioscorea bulbifera with equal sensitivity of 75.0%, also evident in the mean zones of inhibitions, as the highest mean of 15.500mm was observed in Citrus aurantifolia & Sida acuta against all test organisms followed by Citrus aurantifolia & Dioscorea bulbifera (12.667mm) and Sida acuta & Dioscorea bulbifera (12.417mm). Escherichia coli0157:H7 was most sensitive to Sida acuta & Dioscorea bulbifera, Salmonella typhimurium was most sensitive to Citrus aurantifolia & Sida acuta, while Vibrio cholerae was most sensitive to Citrus aurantifolia & Sida acuta. Considering different mean concentrations of combined extracts of 100%, 75%, 50% and 25% against the test organisms, the mean zone of inhibitions was in the order of increasing concentrations, the higher the concentrations the higher their zones of inhibition. The ability of the combined extracts to have shown cleared zone of inhibitions indicates synergism. Keywords: Sida acuta & Citrus aurantifolia, Sida acuta & Dioscorea bulbifera, Citrus aurantifolia & Dioscorea bulbifera, Escherichia coli0157:H7, Salmonella typhymurium, Vibrio cholerae. Synergy, Combined Extracts.

Sida acuta & Citrus aurantifoliaSida acuta & Dioscorea bulbiferaCitrus aurantifolia & Dioscorea bulbiferaEscherichia coli0157:H7Salmonella typhymuriumVibrio cholerae. Synergy+1 more
56,998 views
17,013 downloads

Contributors:

 Amadi-Wali Owhorchukwu
,
 Azuonwu Obioma
,
 Amala Smart Enoch
,
 Wokem Gloria Ngozika